Immuneering said atebimetinib data to be presented at AACR on Pancreatic Cancer suggest the drug may reduce tumor volume while preserving body mass. The poster will be presented by UCSD Health’s Peter Vu on Sept. 26.
published
Immuneering said atebimetinib data to be presented at AACR on Pancreatic Cancer suggest the drug may reduce tumor volume while preserving body mass. The poster will be presented by UCSD Health’s Peter Vu on Sept. 26.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.